- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01568905
Palatability of Experimental Cigarettes - Study 2
October 30, 2019 updated by: University of Minnesota
Palatability of Experimental Cigarettes
Smoking remains a leading cause of preventable disease and premature death worldwide.
Approximately 1 out of every 5 deaths is associated with cigarette smoking, and roughly half of all daily smokers will die prematurely from tobacco-related illness.
Reducing the nicotine in cigarettes to the point that they are rendered non-addictive can potentially be an effective public policy measure that can significantly reduce tobacco-related mortality and morbidity by decreasing the initiation of smoking and promoting cessation.
The Family Smoking Prevention and Tobacco Control Act (FSPTCA) enables the FDA to establish tobacco product standards including placing limits on the allowable nicotine content of cigarettes.
Currently, no reduced nicotine cigarettes are available that will allow studying the feasibility of this policy measure.
The National Institute on Drug Abuse has contracted with Research Triangle Institute to assist in the development of cigarettes with varying nicotine content that can be made available to researchers.
They have established a contract that will result in the manufacture of 9 million cigarettes to be distributed to the research community.
Prior to full production, the palatability and nicotine intake of these cigarettes in smokers must be determined.
Study Overview
Status
Completed
Conditions
Detailed Description
Phase 3: This descriptive study will use a between subjects, double blind design.
This study will test 3 nicotine levels of nicotine, tar and ventilation.
Subjects and research assistants will be blind to the cigarette type.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55414
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-64 years old
- Regular smokers (10+ cigarettes per day and has done so for the last year)
- Inhaling when smoking
- Carbon monoxide (CO) > 8 ppm
Exclusion Criteria:
- In the past year, suffered from any cardiovascular disease such as: heart disease, heart attack, stroke or angina, any respiratory diseases such as chronic bronchitis or chronic obstructive pulmonary disease (COPD), any type of cancer
- Currently suffering from Bipolar Disorder, General Anxiety Disorder, Schizophrenia, or a major depressive episode
- Taken any of the following drugs more than twice per week during the past month: antidepressants, anti-anxiety medications.
- Consumed more than 15 alcoholic drinks per week for the past month
- Pregnant, trying to become pregnant, or lactating (assessed by self-report)
- In the past 3 months, used nicotine replacement products (like the patch, gum, or inhaler), or the medications bupropion varenicline
- Currently trying or planning to reduce or quit tobacco use in the next 30 days
- Used other forms of tobacco 10 or more days in the past 30 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1 Low Level Nicotine Cigarette
(0.4 mg/g)
|
smoke the study cigarette exclusively for one week
|
Experimental: Arm 2 Intermediate Nicotine Level Cigarette
(5.7-5.8 mg/g)
|
smoke the study cigarette exclusively for one week
|
Experimental: Arm 3 High Level Nicotine Cigarette
(11.4-12.8 mg/g)
|
smoke the study cigarette exclusively for one week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in UrineTotal Nicotine Equivalent (TNE) Between Baseline and Week 1
Time Frame: Second Visit (Week 1) minus Baseline (Day 1)
|
Two urine TNE levels are taken, one at baseline and one at week 1, to assess TNE levels for nicotine exposure.
TNE is the sum of nicotine, cotinine, trans 3'-hydroxycotinine and their respective glucuronide conjugates.
Values reported in nmols/ml.
|
Second Visit (Week 1) minus Baseline (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Responses on Modified Cigarette Evaluation Scale
Time Frame: Baseline usual brand cigarettes (Day 1) compared to when using study cigarettes (Week 1)
|
Modified Cigarette Evaluation Scale [CES] is a 100 mm visual analog scale (0=not at all or very little nicotine; 100=extremely or high in nicotine) of 20 questions assessing different dimensions of responses to usual brand cigarettes (e.g., psychological reward, satisfaction and aversiveness) and includes additional 5 point likert-type questions (definitely agree to definitely disagree) on perceptions of satisfaction and willingness to use the product.
Results satisfaction subscale.
|
Baseline usual brand cigarettes (Day 1) compared to when using study cigarettes (Week 1)
|
Change From Baseline of Perceived Health Risk Scale Response to Test Cigarettes
Time Frame: Baseline (Day 1) Compared to Second Visit (Week 1)
|
Questionnaire: Perceived Health Risk Scale asks subjects to rate their perception of health risks for lung cancer for the study product to which they have been randomly assigned.
This is a 100 mm visual analog scale; 0=very low risk of disease, 100=very high risk of disease.
|
Baseline (Day 1) Compared to Second Visit (Week 1)
|
Comparison of Number of Cigarettes Smoked
Time Frame: 1 week
|
Subjects were given a daily diary to collect the number of study and/or conventional cigarettes they have smoked each day.
Cigarettes smoked (both usual brand and experimental) in a given week were summed over the first 7 reported days.
If the number of cigarettes smoked was missing for 1 day, the average of the other days in that week was used in its place and reported as total number of cigarettes per week.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dorothy Hatsukami, Ph.D., Tobacco Use Research Program, University of Minnesota
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
January 3, 2012
First Submitted That Met QC Criteria
March 29, 2012
First Posted (Estimate)
April 2, 2012
Study Record Updates
Last Update Posted (Actual)
November 1, 2019
Last Update Submitted That Met QC Criteria
October 30, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1012M94314
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Low level nicotine cigarette
-
Université Libre de BruxellesCompletedCardiovascular Risk FactorBelgium
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA); University of PennsylvaniaCompleted
-
Chelsea and Westminster NHS Foundation TrustUnknownHand Injuries | Elective Hand SurgeryUnited Kingdom
-
Universita degli Studi di CataniaLaboratory for Health Protection ResearchCompletedTobacco Abuse SmokeItaly
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)TerminatedElectronic CigarettesUnited States
-
Universita degli Studi di CataniaCompleted
-
Milton S. Hershey Medical CenterNational Institute on Drug Abuse (NIDA)Recruiting
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)Recruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); University...CompletedNicotine Dependence | Smoking, Tobacco | Smoking, Cigarette | Exposure to Toxic AgentUnited States
-
Weill Medical College of Cornell UniversityTerminated